Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Aortic Diseases

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Aortic Diseases in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Aortic Diseases: Pathological processes involving any part of the AORTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noma, K1
Goto, C1
Nishioka, K1
Jitsuiki, D1
Umemura, T1
Ueda, K1
Kimura, M1
Nakagawa, K1
Oshima, T1
Chayama, K1
Yoshizumi, M1
Liao, JK1
Higashi, Y1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Aortic Diseases

ArticleYear
Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
    Journal of the American College of Cardiology, 2007, Feb-13, Volume: 49, Issue:6

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Adult; Aortic Diseases; Atherosclerosi

2007